This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Stay extended for US FTC's in-house antitrust case against PBMs

( February 11, 2026, 20:49 GMT | Official Statement) -- MLex Summary: A stay of the US Federal Trade Commissions' in-house enforcement action against pharmacy benefit managers Caremark Rx, OptumRx and their affiliated group purchasing organizations over allegedly inflated insulin prices has been extended for three weeks, an FTC administrative law judge said in an order. Oral argument on the PBMs' motion to dismiss is rescheduled for March 5, the order said. The FTC judge had previously stayed the case for two weeks pending consideration of a proposed consent decree between the agency and some parties.See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections